GlobeNewswire: Veloxis Pharmaceuticals A/S Contains the last 10 of 810 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T14:24:42ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2020/02/17/1985672/0/en/Extraordinary-General-Meeting-of-Veloxis-Pharmaceuticals-A-S-17-February-2020.html?f=22&fvtc=4&fvtv=46862Extraordinary General Meeting of Veloxis Pharmaceuticals A/S, 17 February 20202020-02-17T11:11:22Z<![CDATA[Company Release no. 13/2020]]>https://www.globenewswire.com/news-release/2020/01/29/1976796/0/en/Nasdaq-Copenhagen-A-S-has-Accepted-Veloxis-Pharmaceuticals-A-S-Request-for-Delisting-of-its-Shares-from-Nasdaq-Copenhagen-A-S.html?f=22&fvtc=4&fvtv=46862Nasdaq Copenhagen A/S has Accepted Veloxis Pharmaceuticals A/S' Request for Delisting of its Shares from Nasdaq Copenhagen A/S2020-01-29T13:59:52Z<![CDATA[Company Release no. 12/2020]]>https://www.globenewswire.com/news-release/2020/01/29/1976796/0/da/Offentligg%C3%B8relse-af-Nasdaq-Copenhagen-A-S-Accept-af-Veloxis-Pharmaceuticals-A-S-Anmodning-om-Afnotering-af-Veloxis-Pharmaceuticals-A-S-Aktier-fra-Nasdaq-Copenhagen-A-S.html?f=22&fvtc=4&fvtv=46862Offentliggørelse af Nasdaq Copenhagen A/S' Accept af Veloxis Pharmaceuticals A/S' Anmodning om Afnotering af Veloxis Pharmaceuticals A/S' Aktier fra Nasdaq Copenhagen A/S2020-01-29T13:59:52Z<![CDATA[Selskabsmeddelelse nr. 12/2020]]>https://www.globenewswire.com/news-release/2020/01/24/1975016/0/en/Notice-to-Convene-Extraordinary-General-Meeting.html?f=22&fvtc=4&fvtv=46862Notice to Convene Extraordinary General Meeting2020-01-24T17:17:53Z<![CDATA[Company Announcement no. 11/2020]]>https://www.globenewswire.com/news-release/2020/01/24/1974984/0/en/Announcement-of-Request-for-Delisting-of-Veloxis-Pharmaceuticals-A-S-Shares-from-Nasdaq-Copenhagen.html?f=22&fvtc=4&fvtv=46862Announcement of Request for Delisting of Veloxis Pharmaceuticals A/S' Shares from Nasdaq Copenhagen2020-01-24T16:01:04Z<![CDATA[Company Release no. 10/2020]]>https://www.globenewswire.com/news-release/2020/01/24/1974984/0/da/Offentligg%C3%B8relse-af-Anmodning-om-Afnotering-af-Veloxis-Pharmaceuticals-A-S-Aktier-fra-Nasdaq-Copenhagen-A-S.html?f=22&fvtc=4&fvtv=46862Offentliggørelse af Anmodning om Afnotering af Veloxis Pharmaceuticals A/S' Aktier fra Nasdaq Copenhagen A/S2020-01-24T16:01:04Z<![CDATA[Selskabsmeddelelse nr. 10/2020]]>https://www.globenewswire.com/news-release/2020/01/24/1974964/0/en/Notice-on-Compulsory-Acquisition-to-the-Shareholders-of-Veloxis-Pharmaceuticals-A-S.html?f=22&fvtc=4&fvtv=46862Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S2020-01-24T15:08:11Z<![CDATA[Company Release no. 9/2020]]>https://www.globenewswire.com/news-release/2020/01/24/1974964/0/da/Meddelelse-om-Tvangsindl%C3%B8sning-til-Aktion%C3%A6rerne-i-Veloxis-Pharmaceuticals-A-S.html?f=22&fvtc=4&fvtv=46862Meddelelse om Tvangsindløsning til Aktionærerne i Veloxis Pharmaceuticals A/S2020-01-24T15:08:11Z<![CDATA[Selskabsmeddelelse nr. 9/2020]]>https://www.globenewswire.com/news-release/2020/01/24/1974943/0/en/Veloxis-Pharmaceuticals-A-S-Major-Shareholder-Notifications.html?f=22&fvtc=4&fvtv=46862Veloxis Pharmaceuticals A/S: Major Shareholder Notifications 2020-01-24T14:22:33Z<![CDATA[Company Release no. 8/2020]]>https://www.globenewswire.com/news-release/2020/01/24/1974943/0/da/Veloxis-Pharmaceuticals-A-S-Offentligg%C3%B8relse-af-Storaktion%C3%A6rmeddelelser.html?f=22&fvtc=4&fvtv=46862Veloxis Pharmaceuticals A/S: Offentliggørelse af Storaktionærmeddelelser2020-01-24T14:22:33Z<![CDATA[Selskabsmeddelelse nr. 8/2020]]>